Re: Shenzhen Hepalink-Warrants Expiration
|
3
|
Resverlogix Corp.
|
Feb 05, 2022 10:17AM
|
Re: Merck's profit on Molnupiravir.
|
3
|
Resverlogix Corp.
|
Oct 08, 2021 08:22AM
|
Re: Add one to the list
|
3
|
Zenith Epigenetics
|
Sep 13, 2023 11:47AM
|
Re: ZEN-3694 and Enzalutamide 2b Trial
|
3
|
Zenith Epigenetics
|
Apr 22, 2021 11:11AM
|
Re: Response from Sarah -were still a go
|
3
|
Resverlogix Corp.
|
Dec 02, 2021 01:09PM
|
Re: Response & what I will attempt...
|
3
|
Zenith Epigenetics
|
Aug 15, 2020 02:02PM
|
Re: Where's the kool aid gang?
|
3
|
Resverlogix Corp.
|
May 20, 2022 12:04PM
|
Re: eGFR and Cognition?
|
3
|
Resverlogix Corp.
|
Nov 23, 2019 04:49PM
|
Re: Breakthrough Therapy Designation Application
|
3
|
Resverlogix Corp.
|
Dec 06, 2019 10:48AM
|
Re: Financial Future
|
3
|
Resverlogix Corp.
|
May 13, 2019 12:09PM
|
Re: Clinical trials query results
|
3
|
Zenith Epigenetics
|
Apr 08, 2021 11:41AM
|
Re: One more Exempt Distribution - 2021-04-26
|
3
|
Resverlogix Corp.
|
Apr 28, 2021 10:22AM
|
Re: ZHCLF
|
3
|
Zenith Epigenetics
|
Feb 01, 2024 10:24AM
|
Re: Got this when I inquired (today) about participating in the PP,....
|
3
|
Resverlogix Corp.
|
Jun 03, 2019 06:11PM
|
Re: The Revelation
|
3
|
Resverlogix Corp.
|
Nov 10, 2019 12:46PM
|
Re: Positive data on cognition already 'baked in'?
|
3
|
Resverlogix Corp.
|
Dec 03, 2019 12:10PM
|
Re: Financial Future
|
3
|
Resverlogix Corp.
|
May 13, 2019 12:34PM
|
Re: The chart set up looks awesome imo....
|
3
|
Resverlogix Corp.
|
Dec 03, 2019 12:24PM
|
Interim Financial .... Interim MD&A .... Reporting
|
3
|
Zenith Epigenetics
|
Apr 05, 2024 05:49PM
|
Re: Don's latest presentation
|
3
|
Resverlogix Corp.
|
Sep 22, 2020 09:26AM
|